ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 172 filers reported holding ARRAY BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,339,000 | -92.0% | 28,900 | -95.8% | 0.05% | -91.9% |
Q1 2019 | $16,728,000 | +166.3% | 686,100 | +55.6% | 0.58% | +140.1% |
Q4 2018 | $6,282,000 | -22.3% | 440,800 | -17.1% | 0.24% | -32.6% |
Q3 2018 | $8,082,000 | +60.8% | 531,700 | +77.5% | 0.36% | +31.5% |
Q2 2018 | $5,026,000 | +145.8% | 299,500 | +139.0% | 0.27% | +78.4% |
Q1 2018 | $2,045,000 | +1485.3% | 125,312 | +1146.3% | 0.15% | +1290.9% |
Q4 2017 | $129,000 | -84.2% | 10,055 | -91.7% | 0.01% | -92.1% |
Q3 2016 | $819,000 | – | 121,309 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |